| Literature DB >> 31612126 |
Julia E von Oettingen1, Meghan Craven2, Regina Duperval3, Florence Sine St Surin4, Ronald Eveillard5, Rony Saint Fleur6, Guy Van Vliet7, Jean-Pierre Chanoine8, Renault Louis9.
Abstract
Pediatric specialists are often unavailable in low- and middle-income countries. As part of multiple professional associations' efforts to improve access to endocrine expertise globally, a pediatric endocrine teleconsultation network was established on a store-and-forward teleconsultation platform to facilitate focused, language-appropriate advice that can be kept for future reference while bypassing real-time video-conferencing, and obviating the need for a scheduled appointment. User information was recorded, and quality statistics on network performance and qualitative evaluation by referring physicians were analyzed. Over a 3-year period, 81 referrers (88% from Haiti) and 13 pediatric endocrinologists registered onto the network and discussed 47 pediatric endocrine cases, exchanging a total of 412 messages for a median of 7 messages (IQR 5, 11) per case. Diagnoses spanned the spectrum of pediatric endocrine disorders. According to referrers, an appropriate expert was consulted and an answer provided sufficiently quickly in 100% of cases. The answer was well-adapted to their environment in 86%, and referrers were able to follow the advice given in 72%. All but one referrer found the advice helpful, it clarified the diagnosis in 88%, assisted with management in 93%, improved patient's symptoms in 77%, improved function in 77%, and was considered cost-saving in 50%. Perceived benefits of the consultations were academic instruction, setting-adapted advice beyond the scope of guidelines or textbooks, and advancement in the diagnostic process. Pediatric endocrine remote store-and-forward consultations in low- and middle-income countries may provide a reasonable alternative to face-to-face visits, providing clinical and educational benefit, and a potential for cost-saving.Entities:
Keywords: childhood diabetes; low-resource setting; pediatric endocrinology; store-and-forward networks; teleconsultation
Year: 2019 PMID: 31612126 PMCID: PMC6773829 DOI: 10.3389/fpubh.2019.00272
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Figure 1Schematic diagram of store-and-forward teleconsultation process. The referral process from creation of a new referral to specialist response is shown. Screen shots of the platform as viewed by users on a mobile phone are shown in (A–D).
Consult template.
| 1. Presenting Complaint | |
| 2. History of Presenting Complaint | |
| 3. Past medical history | Birth history:
Gestational age __________(weeks) Birth weight ______________(gm) Birth length (if available)_____(cm) Complications during pregnancy/delivery /perinatal period (specify): Infancy:
Weight gain: average/slow/fast Growth in length: average/slow/fast Development: average/slow/fast Childhood:
Weight gain: average/slow/fast Growth in height: average/slow/fast Development: average/slow/fast |
| 2. Family history | Diabetes Other endocrine disorder Autoimmune disorder Mother's height (if consulting about growth problem, measure parent) Father's height (if consulting about growth problem, measure parent) |
| 3. Anthropometrics and vital signs | Age:(___years, ___months) Weight (kg) __ Length or height (cm) __ |
| 4. Physical examination | General appearance, including signs of dysmorphism: Head/Ears/Eyes/Nose/Throat, including thyroid: Cardiovascular and Respiratory: Abdomen: Genitourinary, including Tanner staging of breast, pubic hair, testicular volume (as indicated) Skin: Neuro: |
| 5. Investigations | |
| 6. Working diagnosis | |
| 7. Current management/treatment | |
| 8. Other | |
CollegiumTelemedicus automatic evaluation questionnaire.
| 1 | Was the case sent to an appropriate expert? |
| 2 | Was the answer provided sufficiently quickly? |
| 3 | Was the answer well-adapted for your local environment? |
| 4 | Were you able to follow the advice given? |
| 5 | If NO, could you explain briefly why no |
| 6 | Did you find the advice helpful? |
| 7a | If YES, did it clarify your diagnosis |
| 7b | If YES, did it assist with your management of the patient? |
| 7c | If YES, did it improve the patient's symptoms |
| 7d | If YES, did it improve function |
| 7e | Any other reason? Please specify |
| 8 | Do you think the eventual outcome for the patient will be beneficial for the patient? |
| 9 | Was there any educational benefit to you in the reply? |
| 10 | Was there any cost-saving as a result of this consultation? |
| 10a | Was there any cost saving for the patient/family |
| 10aa | If YES, please explain briefly |
| 10b | Was there any cost saving for the hospital/clinic |
| 10bb | If YES, please explain briefly |
| 11 | Please add any other comments about this case specifically |
| 12 | Please add any other comments about the service generally |
Participant characteristics.
| Pediatric endocrinologist | 1 | 18 |
| Pediatrician | 49 | 0 |
| Other practicing physician | 0 | 0 |
| Pediatrician in training (resident) | 31 | 0 |
| University Hospital | 70 | 16 |
| Non-university hospital | 3 | 1 |
| Private practice | 6 | 1 |
| Other | 2 | 0 |
| Haiti/Central America | 72 | 0 |
| North America (USA or Canada) | 0 | 13 |
| Europe | 2 | 1 |
| Australia | 0 | 2 |
| South-East Asia | 5 | 0 |
| Africa | 2 | 2 |
| PEEP-H | 70 | 13 |
| GPED | 11 | 5 |
| French | 68 | 16 |
| English | 13 | 11 |
| Spanish | 0 | 3 |
| Arabic | 0 | 1 |
| 1 | 74 | 4 |
| 2 or more | 7 | 14 |
Provisional diagnoses of referred patients by category of suspected endocrine disorder.
| Adrenal | Simple virilizing congenital adrenal hyperplasia in 46 XX child raised as boy | 7 years | M |
| Salt-wasting congenital adrenal hyperplasia | 5 days | Ambiguous | |
| Salt-wasting congenital adrenal hyperplasia | 15 days | F | |
| Premature adrenarche, rule-out congenital adrenal hyperplasia | 5 years | F | |
| Adrenal insufficiency | 3 months | M | |
| Adrenal suppression | 1 year 5 months | F | |
| Cushing's disease | 15 years | M | |
| Cushing's syndrome due to adrenal carcinoma | 2 years 1 month | M | |
| Pseudo-hypoaldosteronism | 1 month | F | |
| Bone | Rickets, nutritional | 3 years | M |
| Osteogenesis imperfecta, type I | 20 days | F | |
| Osteogenesis imperfecta, type IV | 9 years | M | |
| Cardiovascular disease | Hypertension | 12 years | M |
| Diabetes | Type 1 diabetes | 7 years | F |
| Neonatal hyperglycemia due to infection | 2 months | M | |
| New onset type 1 diabetes | 4 years | F | |
| Type 1 diabetes | 1 year, 3 months | F | |
| Neonatal diabetes | 1 month | M | |
| Neonatal diabetes | 2 months | M | |
| Disorders of sexual development | Ambiguous genitalia | 17 days | F |
| Ambiguous genitalia, under-virilized male | n/a | Ambiguous | |
| Ambiguous genitalia, under-virilized male | 5 days | Ambiguous | |
| Ambiguous genitalia, VACTERL (Vertebral defects, Anal atresia, Cardiac defects, Tracheo-esophageal fistula, Renal anomalies, and Limb abnormalities) likely | 20 days | Ambiguous | |
| Under-virilized male | 16 years | M | |
| Vestigial tail ( | n/a | F | |
| Growth | Growth retardation, possible hypopituitarism | 12 years | M |
| Hypoglycemia | Hyperinsulinemic hypoglycemia | 2 years | M |
| Hyperinsulinism,? Beckwith-Wiedemann | 1 days | F | |
| Lipids | Familial hypercholesterolemia | 8 years | F |
| Mucopolysaccharidosis | 9 years | M | |
| Obesity | Early-onset obesity | 1 year | M |
| Puberty | Peripheral precocious puberty (congenital adrenal hyperplasia vs. Leydig cell tumor) | 6 years | M |
| Central precocious puberty | 4 years | F | |
| Central precocious puberty | 4 years | F | |
| Central precocious puberty | 2 years 1 month | F | |
| Premature thelarche | 1 year 6 months | F | |
| Premature thelarche | 1 year 5 months | F | |
| Gynecomastia, rule out prolactinoma or tumor | 13 years | M | |
| Gynecomastia secondary to HIV therapy (Effavirenz) | 14 years | M | |
| Thyroid | Graves' disease | 14 years | NA |
| Rule out hyperthyroidism | 10 years | M | |
| Severe primary hypothyroidism | 6 years | M | |
| Rule out congenital hypothyroidism | 2 months 1 week | M | |
| Rule out congenital hypothyroidism | 2 months | M | |
| Abnormal thyroid function tests | 3 months | M | |
| Sick euthyroid | 7 months | F | |
| Anticipated thyroidectomy due to cervical mass | 3 months 2 weeks | F |
Reasons for referral and consultant diagnoses of urgent consultations by endocrine category.
| Adrenal | Ambiguous genitalia, salt-wasting | Adrenal crisis, salt-wasting Congenital adrenal hyperplasia | Infant | F |
| Diabetes | New onset diabetes with severe ketoacidosis | New onset diabetes with severe ketoacidosis | Child | Unknown |
| New onset diabetes; severe ketoacidosis and cerebral edema | New onset diabetes; severe ketoacidosis and cerebral edema | Child | Unknown | |
| Hyperglycemia | Neonatal diabetes | 2 days | Unknown | |
| Hyperglycemia, seizures | Neonatal diabetes | 2 months | M | |
| Hyperglycemia | Neonatal diabetes vs. stress hyperglycemia, seizures, hypocalcemia | Infant | Unknown | |
| Hypoglycemia | Hypoglycemia | Hypoglycemia likely due to hyperinsulinism, rule out Beckwith-Wiedemann Syndrome | Infant | Unknown |
| Hypoglycemia | Hypoglycemia | 7 years | M | |
| Disorders of sexual development | Ambiguous genitalia | Hymenal skin tag | Infant | F |
| Ambiguous genitalia | Ambiguous genitalia | Infant | Unknown | |
| Puberty | Precocious puberty | Central precocious puberty | Child | F |
| Breast asymmetry | Physiologic breast | Adolescent | F | |
| Gynecomastia, galactorrhea | Physiologic puberty | 13 years | M |